Articles with "tertp mutation" as a keyword



Identification of IDH and TERTp mutation status using 1H‐MRS in 112 hemispheric diffuse gliomas

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Magnetic Resonance Imaging"

DOI: 10.1002/jmri.26964

Abstract: There is a growing interest in noninvasively defining molecular subsets of hemispheric diffuse gliomas based on the isocitrate dehydrogenase (IDH) and telomerase reverse transcriptase gene promoter (TERTp) mutation status, which correspond to distinct tumor entities,… read more here.

Keywords: mutation status; hemispheric diffuse; tertp mutation; diffuse gliomas ... See more keywords

Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss

Sign Up to like & get
recommendations!
Published in 2017 at "Scientific Reports"

DOI: 10.1038/s41598-017-13272-9

Abstract: Astrocytic tumours are the most common type of primary malignant brain tumour. Most astrocytic tumours will recur at some point after surgery. Currently, the combination of radiotherapy and chemotherapy does not prevent the recurrence of… read more here.

Keywords: idh1 tp53; mgmt atrx; astrocytic tumours; tertp mutation ... See more keywords

TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features

Sign Up to like & get
recommendations!
Published in 2021 at "Scientific Reports"

DOI: 10.1038/s41598-021-89906-w

Abstract: Cutaneous basal cell carcinoma (cBCC) is an economic burden to health services, due to its great morbidity and increasing incidence in old people. Infiltrative cBCCs and cBCCs with micronodular pattern are considered as more aggressive.… read more here.

Keywords: cbccs; tertp mutation; expression; p53 expression ... See more keywords

1052 Impact of TERTp Mutation on Meningioma Outcome is Context-Dependent

Sign Up to like & get
recommendations!
Published in 2025 at "Neurosurgery"

DOI: 10.1227/neu.0000000000003360_1052

Abstract: INTRODUCTION: TERT-promoter (TERTp) mutation in meningiomas is associated with worse prognosis and is a biomarker of WHO grade 3 meningioma in the 2021 World Health Organization CNS Tumor Classification. METHODS: We analyzed clinical and molecular… read more here.

Keywords: tertp mutation; tertp mutant; mutant meningiomas; meningiomas ... See more keywords

Clinicopathological Correlation of TERTp (Telomerase Reverse Transcriptase Promoter) Mutation in Meningiomas.

Sign Up to like & get
recommendations!
Published in 2025 at "Neurology India"

DOI: 10.4103/neurol-india.neurol-india-d-23-00146

Abstract: BACKGROUND Identifying meningiomas that behave aggressively has proven challenging based on histopathology alone. Several authors have sought to supplement the World Health Organization (WHO) grading system with the use of molecular markers. Although some genetic… read more here.

Keywords: telomerase reverse; tertp; meningiomas; tertp mutation ... See more keywords